Bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine
C152H198F21N29O — CID 158617093
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine
Bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine (PubChem CID 158617093) has the molecular formula C152H198F21N29O and a molecular weight of 2846.42 g/mol. Its IUPAC name is bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine.
Molecular Properties
| Compound Name | Bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine |
|---|---|
| PubChem CID | 158617093 |
| Molecular Formula | C152H198F21N29O |
| Molecular Weight | 2846.42 g/mol |
| Exact Mass | 2844.60 |
| IUPAC Name | bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine |
| SMILES | C.Cc1ncc(-c2cn(C(C)C)c(C3[C@H]4CC(N5CCOCC5)C[C@@H]34)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3[C@H]4CC(N5CCN(C)CC5)C[C@@H]34)c(CC3CC3)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3[C@H]4CC(N5CCN(C)CC5)C[C@@H]34)c(CC3CC3)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3[C@H]4CC(N5CCN(CCF)CC5)C[C@@H]34)c(CC(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3[C@H]4CC(N5CCN(CCF)CC5)C[C@@H]34)c(CC3CC3)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C3[C@H]4CC(N5CCN(CCF)CC5)C[C@@H]34)c(CC3CC3)n2)cc1C(F)(F)F |
| InChI | InChI=1S/2C26H33F4N5.C26H35F4N5.2C25H32F3N5.C23H29F3N4O.CH4/c2*1-16-22(26(28,29)30)11-18(14-31-16)23-15-35(24(32-23)10-17-2-3-17)25-20-12-19(13-21(20)25)34-8-6-33(5-4-27)7-9-34;1-16(2)10-24-32-23(18-11-22(26(28,29)30)17(3)31-14-18)15-35(24)25-20-12-19(13-21(20)25)34-8-6-33(5-4-27)7-9-34;2*1-15-21(25(26,27)28)10-17(13-29-15)22-14-33(23(30-22)9-16-3-4-16)24-19-11-18(12-20(19)24)32-7-5-31(2)6-8-32;1-13(2)30-12-20(15-8-19(23(24,25)26)14(3)27-11-15)28-22(30)21-17-9-16(10-18(17)21)29-4-6-31-7-5-29;/h2*11,14-15,17,19-21,25H,2-10,12-13H2,1H3;11,14-16,19-21,25H,4-10,12-13H2,1-3H3;2*10,13-14,16,18-20,24H,3-9,11-12H2,1-2H3;8,11-13,16-18,21H,4-7,9-10H2,1-3H3;1H4/t3*19?,20-,21+,25?;2*18?,19-,20+,24?;16?,17-,18+,21?; |
| InChIKey | HXNIABTVBTYJIS-LORKQTBTSA-N |
| XLogP | 28.69 |
| TPSA | 229.13 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 203 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2846.42 |
| LogP ≤ 5 | 28.69 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158617093 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.